Author: Mark Doerr

Mark Doerr is a principal and senior research analyst at Tech Insider covering medical technology companies with a focus on cardiovascular and related therapeutic technology. Mark leverages his prior experience as the director of marketing and business development at a medical device company, along with an extensive network of physician and industry relationships, to provide a unique perspective on the medtech sector. Prior to joining Tech Insider in 2011 he covered medical technology for four years at Craig-Hallum Capital, and has in total 20 years of financial and medtech industry experience.
Finance

Active Stocks: Corinthian Colleges (NASDAQ:COCO), Sirius XM Holdings (NASDAQ:SIRI), General Electric Company (NYSE:GE), GDX, Pfizer Inc. (NYSE:PFE)

Corinthian Colleges Inc. (NASDAQ:COCO), the troubled Orange County for-profit college corporation, has cut a deal with the federal government that’s likely to force the sale of many schools and the closure of others.Corinthian Colleges Inc (NASDAQ:COCO) stock performance was 18.92% in last session and finished the day at $0.397. Traded volume was 23.90million shares in the last session and the average volume of the stock … Continue reading Active Stocks: Corinthian Colleges (NASDAQ:COCO), Sirius XM Holdings (NASDAQ:SIRI), General Electric Company (NYSE:GE), GDX, Pfizer Inc. (NYSE:PFE)

Mark Doerr
Finance

HoT Watch List: Qihoo 360 Technology (NYSE:QIHU), Yandex (NASDAQ:YNDX), Youku Tudou (NYSE:YOKU), Renren Inc (NYSE:RENN), Baidu Inc (ADR) (NASDAQ:BIDU)

Microsoft Corp will work with Chinese Internet security specialist Qihoo 360 Technology Co Ltd (NYSE:QIHU) on mobile Internet and artificial intelligence technology, state media reported, as the U.S. software giant fights security concerns in the country. Microsoft and Qihoo 360 Technology Co Ltd (NYSE:QIHU) on June 9 signed a deal to “cooperate in mobile Internet products” and “technology exchanges in artificial intelligence”, the official Xinhua … Continue reading HoT Watch List: Qihoo 360 Technology (NYSE:QIHU), Yandex (NASDAQ:YNDX), Youku Tudou (NYSE:YOKU), Renren Inc (NYSE:RENN), Baidu Inc (ADR) (NASDAQ:BIDU)

Mark Doerr
Finance

Industrial Goods Volatile Stocks: Chicago Bridge & Iron (NYSE:CBI), Hydrogenics (NASDAQ:HYGS), Hudson Technologies (NASDAQ:HDSN), IntriCon Corporation (NASDAQ:IIN), Micronet Enertec Technologies (NASDAQ:MICT)

Chicago Bridge & Iron Company N.V. (NYSE:CBI) saw unusually large options trading on Tuesday. Stock investors purchased 16,691 put options on the company, Stock Ratings Network.com reports. This represents an increase of 958% compared to the average daily volume of 1,577 put options. Chicago Bridge & Iron Company N.V. (NYSE:CBI) stock performance was -7.23% in last session and finished the day at $68.26. Traded volume … Continue reading Industrial Goods Volatile Stocks: Chicago Bridge & Iron (NYSE:CBI), Hydrogenics (NASDAQ:HYGS), Hudson Technologies (NASDAQ:HDSN), IntriCon Corporation (NASDAQ:IIN), Micronet Enertec Technologies (NASDAQ:MICT)

Mark Doerr
Finance

Watch List: Halliburton Company (NYSE:HAL), Mead Johnson Nutrition CO (NYSE:MJN), Allison Transmission Holdings Inc (NYSE:ALSN), The Gap Inc. (NYSE:GPS), Solazyme Inc (NASDAQ:SZYM)

Halliburton Company (NYSE:HAL) CEO David J. Lesar sold 35,350 shares of Halliburton Company stock on the open market in a transaction that occurred on Thursday, June 12th. The stock was sold at an average price of $67.99, for a total value of $2,403,446.50. Following the transaction, the chief executive officer now directly owns 576,372 shares in the company, valued at approximately $39,187,532. Halliburton Company (NYSE:HAL) … Continue reading Watch List: Halliburton Company (NYSE:HAL), Mead Johnson Nutrition CO (NYSE:MJN), Allison Transmission Holdings Inc (NYSE:ALSN), The Gap Inc. (NYSE:GPS), Solazyme Inc (NASDAQ:SZYM)

Mark Doerr
Finance

Biotech Decliners: Recro Pharma Inc (NASDAQ:REPH), Ignyta Inc (NASDAQ:RXDX), Alder Biopharmaceuticals Inc (NASDAQ:ALDR), Corcept Therapeutics Incorporated (NASDAQ:CORT)

Aegis started coverage on shares of Recro Pharma Inc. (NASDAQ:REPH) in a research note issued on Thursday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $40.00 price target on the stock. Aegis’ price objective suggests a potential upside of 412.16% from the company’s current price. Recro Pharma Inc (NASDAQ:REPH) stock performance was -7.30% in last session and finished the day at $7.24. Traded … Continue reading Biotech Decliners: Recro Pharma Inc (NASDAQ:REPH), Ignyta Inc (NASDAQ:RXDX), Alder Biopharmaceuticals Inc (NASDAQ:ALDR), Corcept Therapeutics Incorporated (NASDAQ:CORT)

Mark Doerr
Finance

NASDAQ Insider Selling: Achillion Pharmaceuticals (NASDAQ:ACHN), Yahoo! Inc. (NASDAQ:YHOO), Broadcom Corporation (NASDAQ:BRCM), Finisar Corporation (NASDAQ:FNSR), Splunk (NASDAQ:SPLK)

Achillion Pharmaceuticals (NASDAQ:ACHN) major shareholder Qvt Associates Gp Llc sold 128,649 shares of the company’s stock in a transaction dated Wednesday, June 11th. The shares were sold at an average price of $7.66, for a total transaction of $985,451.34. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) stock performance was -6.32% in last session and finished the day at $6.83. Traded volume was 21.04million shares in the last session … Continue reading NASDAQ Insider Selling: Achillion Pharmaceuticals (NASDAQ:ACHN), Yahoo! Inc. (NASDAQ:YHOO), Broadcom Corporation (NASDAQ:BRCM), Finisar Corporation (NASDAQ:FNSR), Splunk (NASDAQ:SPLK)

Mark Doerr